6.70
0.00 (0.00%)
| Penutupan Terdahulu | 6.70 |
| Buka | 6.70 |
| Jumlah Dagangan | 26,196 |
| Purata Dagangan (3B) | 34,365 |
| Modal Pasaran | 68,733,288 |
| Harga / Jualan (P/S) | 1.01 |
| Harga / Buku (P/B) | 0.780 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Dec 2024 |
| Margin Keuntungan | -111.18% |
| Margin Operasi (TTM) | -82.06% |
| EPS Cair (TTM) | -7.65 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -7.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 15.92% |
| Nisbah Semasa (MRQ) | 3.11 |
| Aliran Tunai Operasi (OCF TTM) | -144.48 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 7.71 M |
| Pulangan Atas Aset (ROA TTM) | -30.91% |
| Pulangan Atas Ekuiti (ROE TTM) | -68.89% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Bercampur | Bercampur | |
| Stok | Burning Rock Biotech Limited | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.00 |
|
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| % Dimiliki oleh Orang Dalam | 0.04% |
| % Dimiliki oleh Institusi | 60.95% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Skyview Investment Advisors, Llc | 30 Sep 2024 | 10,000 |
| Shen Neil Nanpeng | 30 Sep 2024 | 885 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Dec 2024 | Pengumuman | Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024 |
| 03 Dec 2024 | Pengumuman | Burning Rock Reports Third Quarter 2024 Financial Results |
| 10 Oct 2024 | Pengumuman | NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China |
| 27 Sep 2024 | Pengumuman | Burning Rock Announces Changes to Management and Board of Directors |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |